Aims.
Aims. To assess the safety of
Aims. The intra-articular administration of
Aims.
Aims.
Aims. The aims of this study were to compare the efficacy and safety
of intra-articular and intravenous (IV)
Aims. We chose unstable extra-capsular hip fractures as our study group
because these types of fractures suffer the largest blood loss.
We hypothesised that
Intravenous
Aims. The aim of this study was to investigate the hypothesis that a single dose of
Aims. Cementless primary total hip arthroplasty (THA) is associated with risks of bleeding and thromboembolism. Anticoagulants are effective as venous thromboprophylaxis, but with an increased risk of bleeding.
Aims. This study investigated whether the use of
We performed a randomised, controlled trial involving 150 patients with a pre-operative level of haemoglobin of 13.0 g/dl or less, to compare the effect of either topical fibrin spray or intravenous
We carried out a retrospective case-control study in 80 patients who underwent a revision total hip replacement. Group A (40 patients) received
Aims. Antifibrinolytic agents, including
We investigated the effect of a fibrinolytic inhibitor,
Aims. A typical pattern of blood loss associated with total hip arthroplasty (THA) is 200 ml intraoperatively and 1.3 l in the first 48 postoperative hours.
We report a systematic review and meta-analysis of published randomised controlled trials evaluating the efficacy of